Company snapshot
Market Cap
$158B
Large-cap2016 — today
10-Year Price
+437%
2016 — today
52-Week Range
$332.02$592.85
Current $448.76· 45%
Featured in rankings
S&P500NASDAQMost Undervalued Healthcare StocksMost Undervalued Value StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where ISRG stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| DHRDanaher Corporation | 38.8 | 0.6% |
| PFEPfizer Inc. | 39.6 | 5.7% |
| NVONovo Nordisk A/S | 10.0 | 4.6% |
| VRTXVertex Pharmaceuticals Incorporated | 31.4 | — |
| ABTAbbott Laboratories | 38.7 | 2.4% |
| BMYBristol-Myers Squibb Company | 13.6 | 4.1% |
| MDTMedtronic plc | 24.6 | 3.0% |
| GILDGilead Sciences, Inc. | -52.4 | 2.0% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
53.9
Below average
Below the 10-year average
Sector median 25.2above sector
P/B ratio
9.8
Above average
Pricier than usual over the last 10 years
Sector median 2.2above sector
EV / EBITDA
36.0
Historically cheap
Historically cheap relative to the last 10 years
Sector median 15.4above sector
PEG ratio
4.3
Below average
Below the 10-year average
Sector median 1.8above sector